Literature DB >> 27987135

Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population.

Laura Paláu-Dávila1, Elvira Garza-González2, Eva María Gutiérrez-Delgado1, Adrián Camacho-Ortiz3,4.   

Abstract

BACKGROUND: Factors associated with complicated Clostridium difficile infection (CDI) may vary among populations, and predictors of severe outcomes in CDI have not been studied in Hispanic patients. The aim of this study was to identify factors associated with a higher risk of colectomy, all-cause mortality, and CDI-associated mortality in a Hispanic population.
METHODS: We performed a retrospective study of all hospitalized patients with a diagnosis of CDI between January 1, 2011 and September 30, 2015 in a 450-bed teaching hospital in Monterrey, northeast Mexico. Three main outcomes were defined: fulminant colitis with subsequent colectomy, all-cause mortality within 30 days of diagnosis, and CDI-attributable mortality.
RESULTS: Of 261 patients with diarrhea, 176 were diagnosed with CDI. For colectomy, Charlson comorbidity index, ICU stay and mechanical ventilation prior to CDI diagnosis, days with diarrhea prior to treatment, total days of hospital stay and days after CDI diagnosis, elevated ATLAS score, days of diarrhea post CDI treatment, and treatment failure significantly predicted the necessity of surgical treatment with colectomy.
CONCLUSION: Treatment failure, persistent diarrhea, and a high ATLAS score were identified as risk factors for severe outcomes of CDI. A low albumin concentration and high creatinine were associated with higher overall mortality.

Entities:  

Keywords:  Clostridium difficile infection; Outcome; Predictors; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 27987135     DOI: 10.1007/s12664-016-0722-4

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  13 in total

1.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

2.  Predicting a complicated course of Clostridium difficile infection at the bedside.

Authors:  M P M Hensgens; O M Dekkers; A Goorhuis; S LeCessie; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2013-11-04       Impact factor: 8.067

Review 3.  Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.

Authors:  C Thongprayoon; W Cheungpasitporn; P Phatharacharukul; P J Edmonds; Q Kaewpoowat; P Mahaparn; J Bruminhent; S B Erickson
Journal:  Int J Clin Pract       Date:  2015-07-05       Impact factor: 2.503

4.  Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama.

Authors:  Diana López-Ureña; Carlos Quesada-Gómez; Erick Miranda; Mercedes Fonseca; Evelyn Rodríguez-Cavallini
Journal:  J Med Microbiol       Date:  2013-11-28       Impact factor: 2.472

Review 5.  The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options.

Authors:  Nynke Postma; Dorien Kiers; Peter Pickkers
Journal:  Int J Antimicrob Agents       Date:  2015-11-03       Impact factor: 5.283

6.  Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Authors:  Claire Nour Abou Chakra; Allison McGeer; Annie-Claude Labbé; Andrew E Simor; Wayne L Gold; Matthew P Muller; Jeff Powis; Kevin Katz; Julian R Garneau; Louis-Charles Fortier; Jacques Pépin; Suzanne M Cadarette; Louis Valiquette
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

7.  Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America.

Authors:  C Aguayo; R Flores; S Lévesque; P Araya; S Ulloa; J Lagos; J C Hormazabal; J Tognarelli; D Ibáñez; P Pidal; O Duery; B Olivares; J Fernández
Journal:  Epidemiol Infect       Date:  2015-02-17       Impact factor: 4.434

8.  A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection.

Authors:  Xi Na; Alan J Martin; Saurabh Sethi; Lorraine Kyne; Kevin W Garey; Sarah W Flores; Mary Hu; Dhara N Shah; Kelsey Shields; Daniel A Leffler; Ciarán P Kelly
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

9.  Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.

Authors:  Mark A Miller; Thomas Louie; Kathleen Mullane; Karl Weiss; Arnold Lentnek; Yoav Golan; Yin Kean; Pam Sears
Journal:  BMC Infect Dis       Date:  2013-03-25       Impact factor: 3.090

10.  Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection.

Authors:  Sun Chul Kim; Min Young Seo; Jun Yong Lee; Ki Tae Kim; Eunjung Cho; Myung-Gyu Kim; Sang-Kyung Jo; Won-Yong Cho; Hyoung-Kyu Kim
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.